Ken Sakaie

Ken Sakaie

Auto-generated profile, based on publicly available information

Ken Sakaie

Imaging Institute Cleveland Clinic Cleveland Ohio USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2011 in NeuroImage
Verified
Journal Article
Closed access
PFPierre Fillard
Pierre Fillard
MDMaxime Descoteaux
Maxime Descoteaux
AGAlvina Goh
Alvina Goh
SGSylvain Gouttard
Sylvain Gouttard
BJBen Jeurissen
Ben Jeurissen
CPCyril Poupon
Cyril Poupon

25 April 2008 in Human Brain Mapping
Verified
Journal Article
Closed access
MLMark J. Lowe
Mark J. Lowe
EBErik B. Beall
Erik B. Beall
KSKen E. Sakaie
Ken E. Sakaie
KKKatherine Koenig
Katherine Koenig
LSLael Stone
Lael Stone
MPMicheal D. Phillips
Micheal D. Phillips

1 March 2009 in Experimental Neurology
Verified
Journal Article
Closed access
SMSvjetlana Miocinovic
Svjetlana Miocinovic
SLScott F. Lempka
Scott F. Lempka
GRGary S. Russo
Gary S. Russo
CMChristopher B. Maks
Christopher B. Maks
CBChristopher R Butson
Christopher R Butson
CMCameron C. McIntyre
Cameron C. McIntyre

15 December 2011 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
RFR.J. Fox
R.J. Fox
KSK. Sakaie
K. Sakaie
JLJ.-C. Lee
J.-C. Lee
JDJ.P. Debbins
J.P. Debbins
YLY. Liu
Y. Liu
EFE. Fisher
E. Fisher
BACKGROUND AND PURPOSE: DTI is increasingly being used as a measure to study tissue damage in several neurologic diseases. Our aim was to investigate the comparability of DTI measures between different MR imaging magnets and platforms. MATERIALS AND METHODS: Two healthy volunteers underwent DTI on five 3T MR imaging scanners (3 Trios and 2 Signas) by using a matched 33 noncollinear diffusion-direction pulse sequence. Within each subject, a total of 16 white matter (corpus callosum, periventricular, and deep white matter) and gray matter (cortical and deep gray) ROIs were drawn on a single image set and then were coregistered to the other images. Mean FA, ADC, and longitudinal and transverse diffusivities were calculated within each ROI. Concordance correlations were derived by comparing ROI DTI values among each of the 5 magnets. RESULTS: Mean concordance for FA was 0.96; for both longitudinal and transverse diffusivities, it was 0.93; and for ADC, it was 0.88. Mean scan-rescan concordance was 0.96–0.97 for all DTI measures. Concordance correlations within platforms were, in general, better than those between platforms for all DTI measures (mean concordance of 0.96). CONCLUSIONS: We found that a 3T magnet and high-angular-resolution pulse sequence yielded comparable DTI measurements across different MR imaging magnets and platforms. Our results indicate that FA is the most comparable measure across magnets, followed by individual diffusivities. The comparability of DTI measures between different magnets supports the feasibility of multicentered clinical trials by using DTI as an outcome measure.

14 October 2010 in American Journal of Neuroradiology
Verified
Journal Article
Open access
PDF file
RFR.J. Fox
R.J. Fox
TCT. Cronin
T. Cronin
JLJ. Lin
J. Lin
XWX. Wang
X. Wang
KSK. Sakaie
K. Sakaie
MPM D Phillips
M D Phillips
BACKGROUND AND PURPOSE: DTI is an MR imaging measure of brain tissue integrity and provides an attractive metric for use in neuroprotection clinical trials. The purpose of our study was to use DTI to evaluate the longitudinal changes in brain tissue integrity in a group of patients with MS. MATERIALS AND METHODS: Twenty-one patients with MS starting natalizumab were imaged serially for 12 months. Gadolinium-enhancing lesions and 20 regions of interest from normal-appearing white and gray matter brain tissue were followed longitudinally. Average values within each region of interest were derived for FA, λ∥, λ⊥, and MD. New T1 black holes were identified at 12 months. Analysis was performed by using mixed-model regression analysis with slope (ie, DTI change per month) as the dependent variable. RESULTS: During 1 year, FA increased in gadolinium-enhancing lesions but decreased in NABT (P < .0001 for both). Changes in FA within gadolinium-enhancing lesions were driven by decreased λ⊥ (P < .001), and within NABT, by decreased λ∥ (P < .0001). A higher λ⊥ within gadolinium-enhancing lesions at baseline predicted conversion to T1 black holes at 12 months. MD was unchanged in both gadolinium-enhancing lesions and NABT. CONCLUSIONS: We observed changes in DTI measures during 1 year in both gadolinium-enhancing lesions and NABT. The DTI results may represent possible remyelination within acute lesions and chronic axonal degeneration in NAWM. These results support the use of DTI as a measure of tissue integrity for studies of neuroprotective therapies.

1 April 2015 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
DCDavid A. Cunningham
David A. Cunningham
AMAndre Machado
Andre Machado
DJDaniel Janini
Daniel Janini
NVNicole Varnerin
Nicole Varnerin
CBCorin Bonnett
Corin Bonnett
EPEla B. Plow
Ela B. Plow